SEC Form 4 · accession 0001225208-16-032905
Merck & Co., Inc. · MRK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Rita A Karachun
Officer — Sr. VP Fince-Global Controller
Period of report
May 6, 2016
Accepted (ET)
May 9, 2016 · 4:21 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000310158
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 6, 2016 | M | 2,001 | $0.00 | A | 15,375 | D | |
| Common StockF1 | May 6, 2016 | F | 746 | $54.09 | D | 14,629 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF2 | — | May 6, 2016 | M | 2,001 | D | May 6, 2016 | May 6, 2016 | Common Stock | 2,001 | 0 | D |
Explanation of responses
- F1Holdings include shares acquired in dividend reinvestment transactions.
- F2Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.